Squar Milner Financial Services LLC grew its stake in shares of Steris PLC (NYSE:STE) by 228.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 578 shares of the medical equipment provider’s stock after purchasing an additional 402 shares during the period. Squar Milner Financial Services LLC’s holdings in Steris were worth $88,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Quest Capital Management Inc. ADV acquired a new position in shares of Steris during the 3rd quarter worth $26,000. CWM LLC raised its stake in shares of Steris by 130.9% during the 3rd quarter. CWM LLC now owns 187 shares of the medical equipment provider’s stock worth $27,000 after buying an additional 106 shares during the last quarter. Knuff & Co LLC acquired a new position in shares of Steris during the 3rd quarter worth $29,000. Orrstown Financial Services Inc. acquired a new position in shares of Steris during the 3rd quarter worth $33,000. Finally, Delta Asset Management LLC TN raised its stake in shares of Steris by 28.6% during the 3rd quarter. Delta Asset Management LLC TN now owns 643 shares of the medical equipment provider’s stock worth $93,000 after buying an additional 143 shares during the last quarter. Institutional investors own 86.80% of the company’s stock.
In other news, Director Richard Martin Steeves sold 4,279 shares of Steris stock in a transaction on Friday, December 6th. The stock was sold at an average price of $154.27, for a total transaction of $660,121.33. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have sold a total of 16,093 shares of company stock valued at $2,458,761 in the last ninety days. Corporate insiders own 2.36% of the company’s stock.
Separately, ValuEngine downgraded Steris from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $146.00.
NYSE:STE opened at $152.79 on Thursday. The company has a market capitalization of $13.07 billion, a PE ratio of 38.88 and a beta of 0.88. The company has a quick ratio of 1.86, a current ratio of 2.41 and a debt-to-equity ratio of 0.73. Steris PLC has a 52-week low of $112.25 and a 52-week high of $156.66. The stock has a fifty day simple moving average of $152.07 and a 200-day simple moving average of $148.57.
Steris (NYSE:STE) last released its quarterly earnings results on Monday, November 4th. The medical equipment provider reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.06. The business had revenue of $736.84 million during the quarter, compared to the consensus estimate of $717.79 million. Steris had a return on equity of 16.15% and a net margin of 11.59%. The business’s revenue was up 8.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.10 EPS. As a group, equities analysts anticipate that Steris PLC will post 5.58 earnings per share for the current year.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Recommended Story: Stocks at 52 Week High
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.